{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:20:20Z","timestamp":1780680020752,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.carrev.2012.12.006","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T07:31:05Z","timestamp":1359531065000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intracoronary glycoprotein IIb\/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: Results from the ClearWay\u2122 Multicenter Registry"],"prefix":"10.1016","volume":"14","author":[{"given":"Gabriel","family":"Maluenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron C.","family":"Sizemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Revtyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Cavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley B.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip S.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Deibele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyaprakash","family":"Makam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2012.12.006_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0735-1097(02)01980-0","article-title":"Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention","volume":"40","author":"Singh","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2012.12.006_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/eurheartj\/ehn594","article-title":"Predictors and time-related impact of distal embolization during primary angioplasty","volume":"30","author":"Napodano","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2012.12.006_bb0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(08)60833-8","article-title":"Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study","volume":"371","author":"Vlaar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2012.12.006_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.ATV.21.1.142","article-title":"Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis","volume":"21","author":"Collet","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.carrev.2012.12.006_bb0025","first-page":"211","article-title":"Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA","volume":"48","author":"Bartorelli","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2012.12.006_bb0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/clc.4960241208","article-title":"Acute antithrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab","volume":"24","author":"Shlaifer","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.carrev.2012.12.006_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-8703(00)90014-0","article-title":"Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts","volume":"139","author":"Barsness","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2012.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/01.CIR.0000066852.98038.D1","article-title":"Reduction of adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty","volume":"107","author":"W\u00f6hrle","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCULATIONAHA.109.882746","volume":"121","author":"Deibele","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.108.780718","article-title":"Intracoronary administration of abciximab in ST-elevation myocardial infarction","volume":"118","author":"Gibson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0055","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2012.12.006_bb0060","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/0735-1097(93)90794-2","volume":"22","author":"Ryan","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2012.12.006_bb0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.75.4.817","article-title":"The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis In Myocardial Infarction (TIMI Phase I) trial","volume":"72","author":"Sheehan","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0070","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Sheehan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2012.12.006_bb0075","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Enhanced suppression of the platelet IIb\/IIIa receptor with integrilin therapy. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","author":"ESPRIT Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2012.12.006_bb0080","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1538-7836.2009.03432.x","article-title":"Variability of platelet aggregate dispersal with glycoprotein IIb\u2013IIIa antagonists eptifibatide and abciximab","volume":"7","author":"Speich","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.carrev.2012.12.006_bb0085","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/01.CIR.0000066852.98038.D1","article-title":"Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty","volume":"107","author":"W\u00f6hrle","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.107.747642","volume":"118","author":"Thiele","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2012.12.006_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-006-9000-0","article-title":"Rationale for intracoronary administration of abciximab","volume":"23","author":"Romagnoli","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.carrev.2012.12.006_bb0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2007.04.084","article-title":"Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options","volume":"50","author":"Boden","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838912002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838912002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:08:59Z","timestamp":1761559739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838912002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1553838912002928"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2012.12.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracoronary glycoprotein IIb\/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: Results from the ClearWay\u2122 Multicenter Registry","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2012.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}